Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.117975
Revised: February 3, 2026
Accepted: February 25, 2026
Published online: June 18, 2026
Processing time: 159 Days and 17.6 Hours
Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare malignancy that may lead to complex postoperative complications, including brochobiliary fistula (B
We report a 21-year-old patient with pulmonary metastatic FL-HCC, previously treated with multiple liver ablations, left lung wedge resections, and thoracic radiation, who subsequently developed a right-sided BBF. The patient presented for living donor liver transplantation after persistent bilioptysis and recurrent infections despite biliary drainage and prior surgical repair. Intraoperative mana
This case underscores the significant airway, ventilation, and hemorrhage chal
Core Tip: Bronchobiliary fistula in a patient with fibrolamellar hepatocellular carcinoma creates major anesthetic challenges during liver transplantation, particularly when one-lung ventilation is not tolerated. In this case, despite successful lung isolation with a double-lumen tube, one-lung ventilation resulted in hypoxemia, likely due to impaired pulmonary phy
- Citation: Gomez-Sanchez A, Hilmi IA, Hughes CB, Park D. Bronchobiliary fistula in fibrolamellar hepatocellular carcinoma with anesthetic challenges during living donor liver transplantation: A case report. World J Transplant 2026; 16(2): 117975
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/117975.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.117975
Brochobiliary fistula (BBF) is a rare complication involving the formation of abnormal interconnection between the biliary tract and bronchial trees[1]. Most patients with BBF present with bilioptysis, characterized by scant bile-stained sputum, and may also exhibit other clinical features such as an irritating cough, fever, and jaundice[1,2]. BBF can be classified as congenital or acquired. Acquired cases arise from a wide range of etiologies, including benign hepatic masses, hepatic malignancies, trauma, biliary obstruction, and complications following interventions such as transcatheter arterial chemoembolization or radiofrequency ablation of the liver[3]. The development of BBF is closely associated with hepatobiliary disease as well as surgical and interventional procedures involving these anatomical structures. Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare primary liver cancer that significantly varies from classical hepatocellular carcinoma (HCC)[4]. It is predominantly found in adolescents and young adults without underlying liver disease[5]. Surveillance, Epidemiology, and End Results (SEER) data report an incidence of 0.2 cases per million person-years (< 5% of primary liver tumors), whereas recent computational analyses integrating electronic medical records with national payer data estimate the true United States incidence of FL-HCC at 18.5 cases per million person-years, five to eight times higher than the SEER estimate[6,7]. FL-HCC reported a higher stage at diagnosis, a higher rate of lymph node metastases, and a greater rate of major hepatectomy, when compared with conventional HCC[8]. Liver resection is considered the primary potentially curative treatment. However, liver-directed therapies such as chemoembolization, radioembolization, radiofrequency ablation, and microwave ablation, as well as systemic therapy, may also be used depending on the stage of FL-HCC and the extent of metastasis[9].
We present a case of a patient with FL-HCC complicated by BBF. The patient ultimately underwent living donor liver transplantation as possible curative treatment. To our knowledge, there are no prior reports of patients with BBF under
A 21-year-old female with metastatic FL-HCC complicated by BBF presented for living donor liver transplantation.
The patient presented with worsening bilioptysis (approximately 150 mL/day) and decreased output from her biliary drains in the setting of a known BBF. She had a history of FL-HCC diagnosed in 2020 with a complex subsequent course.
Given the extensive and multifaceted nature of her prior treatments and complications, the detailed clinical timeline is summarized in Table 1.
| Time | Clinical event | Intervention | Outcome/note |
| 2020 (5 years prior) | Diagnosis of FL-HCC | Two cycles of nivolumab | Discontinued due to immune-related type 1 DM and thyroiditis |
| Within first year | Extensive hepatic tumor burden | Ex vivo hepatic tumor resection with Roux-en-Y hepaticojejunostomy | Major alteration of biliary anatomy |
| Following years | Tumor recurrence | Microwave ablation and radioembolization | Progressive hepatic injury |
| 4 years after diagnosis | Pulmonary metastasis | Left lung wedge resection and stereotactic radiation to both lungs | Radiation exposure to lung parenchyma |
| Subsequent course | Development of hepatic bilomas, intrahepatic abscesses, polymicrobial cholangitis | Internal–external biliary drainage | Recurrent sepsis and chronic biliary complications |
| Later period | Development of BBF | Surgical repair with diaphragmatic reconstruction | Recurrent fistulae and persistent bilioptysis |
| Preoperative period | Drain malfunction and persistent BBF | IR exchange and repositioning of chest tube, biloma drain, biliary drain | Multiple drains present in right hemithorax and RUQ |
| Preoperative status (2025) | Dyspnea on exertion, bilioptysis, poor nutritional status (BMI: 16) | Evaluation for surgery | Compromised pulmonary and systemic condition |
| Final stage | Persistent BBF with metastatic FL-HCC | Referral for living donor liver transplantation | Considered as potential curative option |
The patient had no personal history of cancer or underlying liver disease. Her family history was notable for a maternal grandmother with breast cancer, with the patient’s mother testing negative for BRCA mutations, and a maternal gr
The patient appeared chronically ill and jaundiced, reporting notable pruritus, decreased appetite, malaise, and fatigue; her body mass index was 16. Preoperative vital signs were blood pressure 114/65 mmHg, heart rate 99 beats/minute, respiratory rate 16 breaths/minute, oxygen saturation 97% on room air, and temperature 36.4 °C. Airway evaluation revealed a Mallampati class I view, normal cervical range of motion, adequate mouth opening and intact dentition. She endorsed dyspnea on exertion, abdominal pain, and intermittent episodes of coughing up bile.
No special notes.
Chest computed tomography (CT) showed a right lung mass and fluid along the right major fissure, secondary to BBF (Figure 1A and B). Abdomen CT showed significant hepatomegaly, splenomegaly, and multiple liver masses (Figure 1C).
Recent imaging confirmed drain malfunction and persistent BBF. Interventional radiology exchanged and repositioned the right-sided chest tube and biliary drains, with preoperative radiography confirming their placement in the right hemi
A diagnosis of pulmonary metastatic FL-HCC with persistent BFF was established. She was subsequently referred for living donor liver transplantation as a potential curative treatment option.
The patient was brought to the operating room with standard ASA monitors, along with a 20-gauge left radial arterial line and peripheral IV in place. Given the risk of aspiration and anticipated airway complexity, a rapid sequence indu
| Baseline after anesthesia | After resumed TLV | After native liver out | 5 minutes after reperfusion | 90 minutes after reperfusion | |
| Ventilation | OLV | TLV | TLV ± OLV | TLV | TLV |
| FiO2 (%) | 100 | 89 | 67 | 70 | 70 |
| SpO2 (%) | 94 | 99 | 100 | 100 | 99 |
| PIP (cmH2O) | 24 | 20 | 23 | 19 | 18 |
| ABP (mmHg) | 137/57 | 114/54 | 137/62 | 125/58 | 108/58 |
| pH | 7.33 | 7.35 | 7.42 | 7.36 | 7.44 |
| PaCO2 (mmHg) | 49 | 43 | 52 | 43 | 44 |
| PaO2 (mmHg) | 83 | 140 | 220 | 202 | 161 |
| HCO3- (mmol/L) | 26 | 24 | 33 | 25 | 29 |
| Base excess/deficit | -0.1 | -1.7 | 7.9 | -0.9 | 4.6 |
| Hb (g/dL) | 8.2 | 7.8 | 7.2 | 8.9 | 10.6 |
| K+ (mmol/L) | 3.6 | 3.5 | 4.9 | 3.5 | 3.4 |
| Lactate (mmol/L) | 1.10 | 1.10 | 4.60 | 4.80 | 4.00 |
Due to anatomic variation, the left internal jugular vein could not be cannulated; therefore, the right internal jugular vein was used for placement of both an 8 Fr Swan-Ganz catheter and a 9 Fr central venous catheter. An additional radial arterial line was placed in the contralateral side, and a 7 Fr rapid infusion catheter was inserted into the left antecubital vein. Although veno venous bypass was requested, no additional right-sided access was available due to existing large-bore catheters.
The surgical procedure was technically challenging due to dense perihepatic adhesions, extensive liver adherence to the diaphragm and inferior vena cava, and complex biliary reconstruction. Operative exploration revealed two percu
Estimated blood loss was approximately 4 liters. A massive transfusion protocol was activated, including administration of 17 units of packed red blood cells, 8 units of fresh frozen plasma, 3 platelet units, 3 units of cryoprecipitate, 10 liters of crystalloid, and 600 mL of 5% albumin. Hemodynamic stability was primarily maintained through early and aggressive volume and blood product resuscitation. A norepinephrine infusion was initiated transiently at the time of reperfusion to support systemic vascular tone and was required only for a short duration. The infusion was gradually tapered and discontinued by the end of the procedure, allowing most of the operation to be completed with minimal vasopressor support. Calcium supplementation and methylene blue were administered per institutional protocol to correct electrolyte abnormalities and address vasoplegia. Urine output remained robust, totaling 5.6 liters throughout the procedure. At the surgeon’s request, an octreotide infusion was initiated to modulate portal venous flow through the newly implanted liver, and intraoperative Doppler ultrasonography confirmed adequate graft perfusion.
At the end of surgery, the DLT was exchanged for an 8.0 mm single-lumen tube. The patient was transferred intubated to the transplant intensive care unit, hemodynamically stable and no longer requiring vasoactive support. Sedation and analgesia were titrated to ensure ventilator synchrony and minimize coughing.
The patient was extubated on postoperative day 1 by the critical care team and maintained stable respiratory status on
Management of BBF can be very difficult and is often associated with a high rate of morbidity and mortality. There has been no widely accepted management strategy in this condition[1]. In the absence of established treatment guidelines, management of BBF is typically individualized according to the underlying etiology and hepatobiliary pathology. Recent advances have broadened therapeutic options through minimally invasive and endoscopic techniques, including endoscopic sphincterotomy, biliary stent placement, and percutaneous transhepatic biliary drainage for biliary decom
Our case may be considered unique in several respects. Firstly, liver transplantation was undertaken as a potential curative treatment for BBF associated with hepatic malignancy. Although living donor transplantation is a complex decision involving surgical, ethical, and donor-related considerations, this case highlights that transplantation may serve as a definitive treatment option in selected patients, as it addresses both the BBF and the underlying hepatic disease contributing to its development.
Secondly, this case highlights important anesthetic challenges related to airway and ventilation management in pa
Chronic biliary contamination of the respiratory tract can lead to recurrent pneumonitis, progressive respiratory compromise from airway irritation, and systemic complications such as malnutrition and sepsis[11]. The literature on anesthetic management in BBF is limited and consists primarily of case reports, which emphasize strategies aimed at preventing positive-pressure ventilation before lung isolation to avoid contamination of the contralateral lung with bile[12,13]. The summary of published case reports describing anesthetic management of BBF is provided in Table 3. In most reported cases, DLT with fiberoptic bronchoscopy was successfully performed, and OLV was maintained throughout surgery. DLTs are generally preferred because they facilitate reliable lung isolation and allow continuous suctioning of bile-stained secretions[12-14]. In a combined liver-kidney transplant in which BBF was discovered intraoperatively, emergent selective lung isolation using a Fogarty catheter was necessary to control a massive air leak and prevent cross-contamination prior to surgical repair[15]. Only one case had underlying pulmonary infection with poor lung function, in which repeated saline suctioning of biliary spillage from the affected lung was required until fistula ligation[14].
| Sex/age | Primary disease | Biloptysis | Fistula affected lung | Pre-existing pulmonary disease | Surgery | Surgical position | Anesthesia | Endotracheal tube | Ventilation mode | Anesthetic challenge | |
| 1 | Male/44 | BBF after pancreaticoduodenectomy | Yes | Right | Pneumonia | Resection of fistula and bilobectomy | Left lateral decubitus position | GA | Left-sided DLT | OLV | Initially saturation decreased but gradually increased. Repeated bronchial lavage |
| 2 | Female/64 | BBF with thrombosed hepatic artery aneurysm | Yes | Right | No | Deceased donor liver retransplantation | Supine position | GA | 37-Fr left-sided DLT | OLV with CPAP in the right lung | After skin closure, approximately 500 mL/minute air leak from a suspected residual right bronchopleural fistula was detected during TLV, so OLV was resumed |
| 3 | Male/58 | BBF with prior hepatic hydatid cyst resection | Yes | Right | No | Thoracotomy and resection of fistula and lobectomy | Left lateral decubitus position | GA | 37-Fr left-sided DLT | OLV | - |
| 4 | Male/61 | Intrahepatic cholangiocarcinoma | Yes | N/A | No | ERCP | N/A | GA | 8.0 mm SLT | TLV | A spontaneous bronchobiliary fistula to the right bronchial tree was identified intraoperatively, and the patient was reintubated with a DLT |
| 5 | Male/20 | BBF with prior exploratory laparotomy for grade 4 liver injury due to a blunt abdominal trauma | Yes | Right | No | ERCP and placement of a biliary stent | Prone and slight head-up position | MAC | N/A | SV | Temporarily hypotensive initially and thereafter remained hemodynamically stable |
| 6 | Male/66 | Polycystic kidney disease and ESLD | Yes | NA | No | Combined liver-kidney transplantation | Supine position | GA | SLT and using a fogarty catheter | TLV | Identified intraoperative BBF with significant air leak; selective segmental isolation using a fogarty catheter |
In our case, OLV using DLT was initially planned and successfully achieved with isolation of the affected right lung. However, OLV could not be maintained intraoperatively, necessitating conversion to TLC with frequent airway suc
The patient described in this case report had a five-year history of FL-HCC with pulmonary metastases, treated with multiple surgeries and ablations, resulting in chronic liver disease with ongoing hepatocellular injury, as reflected by a high model for end-stage liver disease-sodium (MELD-Na) score of 25. Such injury is known to trigger overproduction of potent vasodilators, including nitric oxide and carbon monoxide, leading to precapillary and capillary dilatation and the formation of intrapulmonary arteriovenous shunts[18]. This pathophysiology likely produced a pre-existing ventilation-perfusion mismatch and attenuated HPV, thereby compromising a key compensatory mechanism required to maintain oxygenation during OLV, which may partly explain the difficulty encountered in our patient.
Another possible cause of the failure of OLV can be explained by the fact that the patient had prior left lung wedge resection and radiation therapy on both lungs. Radiation-induced lung injury refers to pulmonary damage following thoracic radiation caused by destruction of alveolar epithelial and endothelial cells and disruption of the alveolar-capillary barrier[19,20]. This injury initiates an inflammatory cascade with increased vascular permeability, macrophage activation, and release of reactive oxygen and nitrogen species and profibrotic cytokines, resulting first in radiation pneumonitis and later in chronic pulmonary fibrosis[19]. These structural and inflammatory changes lead to progressive deterioration in lung function. The patient’s history of recurrent pneumonitis and pneumonia requiring antibiotic treatment suggests that her baseline pulmonary function was likely already compromised. This may also have con
Because TLV was required to maintain oxygenation, vigilant anesthetic management was essential, including frequent suctioning of bile from the right bronchus to limit contamination of the contralateral lung. Continuous airway clearance and serial arterial blood gas monitoring enabled dynamic ventilatory adjustments and physiological stability despite ongoing biliary contamination. This experience emphasizes the importance of anticipating potential OLV failure based on preoperative pulmonary status and the previously described physiologic mechanisms expected in a patient with chronic liver disease, rending preparation for an alternative ventilation strategy in advance a key for anesthetic management.
Extensive intra-abdominal adhesions significantly prolonged the hepatectomy phase, which lasted 435 minutes. A key intraoperative finding was the percutaneous biliary drain tract, with one catheter traversing the diaphragm into the liver and directly communicating with the right pleural cavity, likely representing the main pathway for bile entry into the bronchial system and the cause of persistent bilioptysis. The dense perihepatic adhesions and adherence of the liver to the diaphragm and inferior vena cava contributed to prolonged operative time and substantial blood loss. Regarding fluid and transfusion management, the patient required massive transfusion. Massive transfusion is defined as intraoperative transfusion of ≥ 10 units of packed red blood cells[22]. Although the evidence indicates that intraoperative blood transfusion is linked to worse postoperative outcomes in liver transplant recipients[23], transfusion remains frequently unavoidable during liver transplantation for intraoperative blood loss due to coagulopathy and surgical blood loss. In our case, massive transfusion was required, and hemodynamic support stability was maintained with norepinephrine, and calcium and methylene blue were administered to address electrolyte disturbances and vasoplegia. Recurrent laboratory assessments allowed timely correction of coagulopathy, acid-base derangements, and hyperglycemia. Prior studies have demonstrated that massive transfusion during orthotopic liver transplantation is independently associated with factors such as previous right-sided abdominal surgery, low preoperative hemoglobin, elevated model for end-stage liver disease score, prolonged cold and warm ischemia times, and extended operative duration. These variables serve as important predictors of substantial intraoperative blood loss in complex transplant cases[22]. Our patient exhibited several established predictors of perioperative complexity, including a history of extensive prior abdominal surgery, a high MELD-Na score of 25, preoperative anemia with a hemoglobin of 9.2 g/dL, prolonged cold ischemia time of 237 minutes, and an extended operative duration of 13.3 hours. Regarding vascular access, veno venous bypass was not feasible because an anatomic variation of the left internal jugular vein precluded cannulation, limiting central venous access to the right internal jugular vein. In anticipation of potential massive transfusion, a 7-Fr rapid infusion catheter was placed via antecubital access for blood product administration, highlighting the importance of proactive vascular access planning in liver transplant anesthetic management.
This case illustrates the complexity of anesthetic and surgical challenges during liver transplantation in a patient with BBF and FL-HCC with pulmonary metastases. The inability to sustain OLV was not due to technical difficulty with lung isolation, but rather to impaired pulmonary physiology related to HPS, prior lung resection, and radiation-induced lung injury. Transition to TLV with frequent airway clearance and close physiologic monitoring allowed adequate oxygenation until removal of the native liver eliminated the source of bile entry into the bronchial tree. The operation was further complicated by dense intra-abdominal adhesions, prolonged hepatectomy, and substantial blood loss requiring massive transfusion, highlighting the importance of early vascular access planning, coordinated transfusion strategy, and vigilant hemodynamic management in complex transplant cases. This experience underscores the need to anticipate potential failure of OLV in patients with BBF and compromised pulmonary reserve, and to prepare alternative ventilation and resuscitation strategies tailored to the patient’s underlying physiology and surgical complexity.
The authors extend their gratitude to the patient and her family for consenting to share this case. We also acknowledge the contributions of the perioperative, surgical, and critical care teams who coordinated efforts made this work possible.
| 1. | Liao GQ, Wang H, Zhu GY, Zhu KB, Lv FX, Tai S. Management of acquired bronchobiliary fistula: A systematic literature review of 68 cases published in 30 years. World J Gastroenterol. 2011;17:3842-3849. [PubMed] [DOI] [Full Text] |
| 2. | Eryigit H, Oztas S, Urek S, Olgac G, Kurutepe M, Kutlu CA. Management of acquired bronchobiliary fistula: 3 case reports and a literature review. J Cardiothorac Surg. 2007;2:52. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 67] [Cited by in RCA: 57] [Article Influence: 3.0] [Reference Citation Analysis (0)] |
| 3. | Tocchi A, Mazzoni G, Miccini M, Drumo A, Cassini D, Colace L, Tagliacozzo S. Treatment of hydatid bronchobiliary fistulas: 30 years of experience. Liver Int. 2007;27:209-214. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 39] [Cited by in RCA: 38] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
| 4. | Riggle KM, Turnham R, Scott JD, Yeung RS, Riehle KJ. Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma. Pediatr Blood Cancer. 2016;63:1163-1167. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 33] [Cited by in RCA: 37] [Article Influence: 3.7] [Reference Citation Analysis (0)] |
| 5. | Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980;46:372-379. [PubMed] [DOI] [Full Text] |
| 6. | Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J. 2013;1:351-357. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 104] [Cited by in RCA: 95] [Article Influence: 7.3] [Reference Citation Analysis (0)] |
| 7. | Zack T, Losert KP, Maisel SM, Wild J, Yaqubie A, Herman M, Knox JJ, Mayer RJ, Venook AP, Butte A, O'Neill AF, Abou-Alfa GK, Gordan JD. Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data. NPJ Precis Oncol. 2023;7:29. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 13] [Reference Citation Analysis (0)] |
| 8. | Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP, Shama MA, Chun YS. Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma. J Gastrointest Surg. 2016;20:1725-1731. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 30] [Cited by in RCA: 47] [Article Influence: 4.7] [Reference Citation Analysis (1)] |
| 9. | Glavas D, Bao QR, Scarpa M, Ruffolo C, Brown ZJ, Pawlik TM, Spolverato G. Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis. J Gastrointest Surg. 2023;27:705-715. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 19] [Reference Citation Analysis (0)] |
| 10. | Yu X, Ding Y, Zhang Y, Chen B, Hua YP, Li SQ, Dai ZH, Liu JF, Shen SL. Treatment of bronchobiliary fistula: a 13-year experience. BMC Surg. 2025;26:21. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 11. | Mitra S, Bhatia N, Dey N, Dalal U. Bronchobiliary fistula: an anesthetic challenge! J Clin Anesth. 2009;21:360-362. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 5] [Cited by in RCA: 4] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 12. | Carr A, Gonzalez N, Hernandez-Alejandro R, Arellano R. A Case Report of the Anesthetic Management for Liver Retransplantation in a Patient With a Bronchobiliary Fistula. A A Case Rep. 2016;7:219-221. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 2] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 13. | Rokhtabnak F, Baghai-Wadji M, Morovati Sharifabadi P, Nouri N. Anesthetic Management of Bronchobiliary Fistula as a Complication of Liver Hydatid Cyst: A Case Report. Med J Islam Repub Iran. 2024;38:66. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 14. | Lee J, Jung SM, Lee Y, Kim SY. Anesthetic management for a patient with bronchobiliary fistula after pancreaticoduodenectomy: A case report. Medicine (Baltimore). 2019;98:e15694. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 2] [Cited by in RCA: 5] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
| 15. | Stock E, Vannucci A, Doyle M, Patterson GA, Chapman W, Kangrga I. Combined liver-kidney transplantation complicated by intraoperative discovery of a bronchobiliary fistula. Transplant Proc. 2010;42:2800-2803. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 2] [Article Influence: 0.1] [Reference Citation Analysis (0)] |
| 16. | Benumof JL. One-Lung Ventilation and Hypoxic Pulmonary Vasoconstriction. Anesth Analg. 1985;64:821-833. [RCA] [DOI] [Full Text] [Cited by in Crossref: 150] [Cited by in RCA: 110] [Article Influence: 2.7] [Reference Citation Analysis (0)] |
| 17. | Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20:8072-8081. [PubMed] [DOI] [Full Text] |
| 18. | Zaka AZ, Mangoura SA, Ahmed MA. New updates on hepatopulmonary syndrome: A comprehensive review. Respir Med. 2025;236:107911. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 5] [Reference Citation Analysis (1)] |
| 19. | Arroyo-Hernández M, Maldonado F, Lozano-Ruiz F, Muñoz-Montaño W, Nuñez-Baez M, Arrieta O. Radiation-induced lung injury: current evidence. BMC Pulm Med. 2021;21:9. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 104] [Cited by in RCA: 261] [Article Influence: 52.2] [Reference Citation Analysis (0)] |
| 20. | Choi YW, Munden RF, Erasmus JJ, Park KJ, Chung WK, Jeon SC, Park CK. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics. 2004;24:985-97; discussion 998. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 222] [Cited by in RCA: 210] [Article Influence: 10.0] [Reference Citation Analysis (0)] |
| 21. | Campos JH, Feider A. Hypoxia During One-Lung Ventilation-A Review and Update. J Cardiothorac Vasc Anesth. 2018;32:2330-2338. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 47] [Cited by in RCA: 86] [Article Influence: 9.6] [Reference Citation Analysis (0)] |
| 22. | Alhamar M, Uzuni A, Mehrotra H, Elbashir J, Galusca D, Nagai S, Yoshida A, Abouljoud MS, Otrock ZK. Predictors of intraoperative massive transfusion in orthotopic liver transplantation. Transfusion. 2024;64:68-76. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 11] [Article Influence: 5.5] [Reference Citation Analysis (0)] |
| 23. | Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth. 2005;52:148-155. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 114] [Cited by in RCA: 116] [Article Influence: 5.5] [Reference Citation Analysis (0)] |